Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fine

Showing results (191-200 of 241) with videos related to

Pageof 25
Sort By:
The American Journal of Surgical Pathology|January 21, 2014
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistryYing-Bei Chen, A Rose Brannon, Antoun Toubaji, et al.
BJU International|June 23, 2021
Clinical utility of subclassifying positive surgical margins at radical prostatectomyShawn Dason, Emily A Vertosick, Kazuma Udo, et al.
The Journal of Urology|October 10, 2018
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate CancerYujiro Ito, Kazuma Udo, Emily A Vertosick, et al.
The Journal of Urology|August 5, 2018
Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerLucas W Dean, Melissa Assel, Daniel D Sjoberg, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2018
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate CancerLiana B Guedes, Carlos L Morais, Helen Fedor, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
The American Journal of Surgical Pathology|May 2, 2015
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologistsRajal B Shah, Jianbo Li, Liang Cheng, et al.
Urologic Oncology|February 15, 2021
Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancerGregory T Chesnut, Amy L Tin, Arjun Sivaraman, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
Pageof 25

Showing results (191-200 of 241) with videos related to

Sort By:
Pageof 25
The American Journal of Surgical Pathology|January 21, 2014
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistryYing-Bei Chen, A Rose Brannon, Antoun Toubaji, et al.
BJU International|June 23, 2021
Clinical utility of subclassifying positive surgical margins at radical prostatectomyShawn Dason, Emily A Vertosick, Kazuma Udo, et al.
The Journal of Urology|October 10, 2018
Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate CancerYujiro Ito, Kazuma Udo, Emily A Vertosick, et al.
The Journal of Urology|August 5, 2018
Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate CancerLucas W Dean, Melissa Assel, Daniel D Sjoberg, et al.
Archives of Pathology & Laboratory Medicine|October 9, 2018
Effect of Preanalytic Variables on an Automated PTEN Immunohistochemistry Assay for Prostate CancerLiana B Guedes, Carlos L Morais, Helen Fedor, et al.
Prostate Cancer and Prostatic Diseases|February 26, 2020
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancerSounak Gupta, Chad Vanderbilt, Wassim Abida, et al.
The Journal of Pathology|May 7, 2011
Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinomaHikmat A Al-Ahmadie, Gopa Iyer, Manickam Janakiraman, et al.
The American Journal of Surgical Pathology|May 2, 2015
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologistsRajal B Shah, Jianbo Li, Liang Cheng, et al.
Urologic Oncology|February 15, 2021
Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancerGregory T Chesnut, Amy L Tin, Arjun Sivaraman, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 14, 2019
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancerToshikazu Takeda, Amy L Tin, Renato B Corradi, et al.
Pageof 25